Featured Post from Augusta University

New LIV Golf series raises plenty of questions and eyebrows

Jun 27, 2022

2 min

Richard Franza, PhD


When the new LIV Golf series backed by Saudi Arabia came into existence, it raised plenty of questions on who would jump from the PGA Tour to this new league. With guaranteed appearance fees in the millions offered, it wasn’t a huge surprise some of the biggest stars like Phil Mickelson, Dustin Johnson Brooks Koepka and Bryson DeChambeau have decided to join.



Some of pushback to the new league comes as a result of the Saudis' track record on human rights issues.


The PGA Tour had warned players there would be repercussions of playing in those events and responded by suspending those who are, indefinitely.


But can they legally do that?


Richard Franza, dean of the Hull College of Business said golfers are independent contractors and the suspensions may end up being challenged in court.



“Nothing will be resolved until it goes to court,” said Franza. “I think there are three things that could determine if it goes to court or not. First — if someone is playing LIV Golf wants to play in a PGA Tour event and they are barred. Second — if somehow the stance on majors changes, which I think is very plausible. Third — will these guys be included in the official World Golf Rankings? This is important because the OWGR help determine automatic entry into the majors.”


Right now, golf’s four majors, the Masters, U.S. Open, PGA Championship and The Open Championship, are not run by the PGA Tour and have indicated they would not bar those playing in the LIV Golf series.


It’s apparent to most this is a money move by the players. With the millions of dollars being guaranteed to Mickelson, Johnson and others, they are securing their future.


There are also only eight events in the LIV Golf series with a team component. Each tournament is just three rounds, compared to the four in a PGA Tour event.



Franza said they may also be challenging the PGA Tour to change how they do business.


“I think in the grand scheme of things the guys would like to stay with the PGA Tour. But for some of them, it’s a way to try to get the PGA Tour to change things. I don’t know if they (LIV players) are looking for guarantees or not, but they’re probably looking for bigger purses, although purses have already gotten pretty big. I think they may want different events that aren’t all stroke play events,” added Franza.


In fact, the PGA Tour has recently announced significant purse increases for some of their tournaments as a response to the LIV Golf series.



If you're looking to know more about what's next for players and the business side of golf, then let us help.



Richard Franza is available to speak with media  – simply click on his icon now to arrange an interview today.

Connect with:
Richard Franza, PhD

Richard Franza, PhD

Faculty, James M. Hull College of Business

Dr. Richard M. Franza is a professor and former dean of the James M. Hull College of Business.

ManagementOperations ResearchEntreprenuershipIntentional LeadershipHigher Education Leadership
Powered by

You might also like...

Check out some other posts from Augusta University

Can a Mother's ZIP Code Shape a Baby's Future? featured image

2 min

Can a Mother's ZIP Code Shape a Baby's Future?

Where an expectant mother lives might reveal important clues about her baby's health before birth. According to a recent Augusta University Jagwire article, researchers at the Medical College of Georgia have found that mapping birth outcomes by ZIP code can help identify communities where mothers and newborns face greater health risks, providing valuable information for healthcare providers and public health officials. The two-part study out of the Department of Anesthesiology and Perioperative Medicine at the Medical College of Georgia at Augusta University, led by Mary Arthur, MD, explored the relationship between neighborhood characteristics and neonatal outcomes. By combining geographic mapping with maternal and infant health data, the researchers identified areas with higher rates of adverse birth outcomes and examined how factors such as access to prenatal care and other social determinants of health might contribute to those disparities. The findings suggest that geographic data can become a valuable tool for improving maternal and infant health. By identifying communities at greater risk, healthcare systems and policymakers can better target prenatal education, outreach programs and healthcare resources to support expectant mothers before complications arise. For journalists covering maternal health, healthcare disparities and public policy, Arthur offers valuable insight into how community-level data can help guide interventions that improve pregnancy outcomes and give more babies a healthier start in life. "The maps make it very easy to visualize those ZIP codes that link to poor neonatal outcomes. They're also helpful for planning strategic interventions to help the people who live in those particular areas in terms of making sure there are outreach programs for mothers in those areas to have access to prenatal care." Mary Arthur, MD To learn more about this important research and connect with Mary Arthur, contact AU's External Communications Team mediarelations@augusta.edu to arrange an interview today.

Can One Gene Change the Future of Heart Disease? featured image

2 min

Can One Gene Change the Future of Heart Disease?

Heart disease remains the world's leading cause of death, but researchers are continuing to uncover the genetic mechanisms that drive it. According to a recent Augusta University Jagwire article highlighting new research, scientists are investigating how a little-studied gene might influence the development of cardiovascular disease and whether it could become a future target for treatment. At the center of the research is Kunzhe Dong, PhD, an investigator at Augusta University's Immunology Center of Georgia, who is examining the role of the SH3BGRL2 gene in cardiovascular cells. While the gene has previously been associated with cancer biology, early findings suggest it might also play an important role in regulating how blood vessels respond to stress and injury. Understanding that relationship could reveal new biological pathways involved in heart disease and identify novel opportunities for precision medicine. The research aims to determine how changes in gene expression affect the function of cardiovascular cells and contribute to disease progression. By better understanding these molecular mechanisms, scientists hope to identify new therapeutic targets and improve the ability to prevent or treat cardiovascular disease before irreversible damage occurs. The work also reflects a broader shift toward precision medicine, where treatments are tailored to the underlying biology of each patient rather than relying solely on traditional risk factors. "This gene is well known in one field, but now we're seeing it's also important in cardiovascular cells." Kunzhe Dong, PhD To learn more about this research and connect with Kunzhe Dong, contact AU's External Communications Team mediarelations@augusta.edu to arrange an interview today.

Heart Disease's Hidden Immune Players Come Into Focus featured image

2 min

Heart Disease's Hidden Immune Players Come Into Focus

Heart disease has long been linked to familiar risk factors such as high cholesterol, high blood pressure and lifestyle choices. But according to a recent Augusta University Jagwire article highlighting research published in Nature Reviews Cardiology, the immune system might also play a critical role in determining how cardiovascular disease develops and progresses. The review, led by Ishita Tandon, PhD, Hossam Abdelsamed, PhD, and Alaa M. Khalifa, PhD, examines the emerging role of CD8+ T cells, specialized immune cells best known for fighting infections, in atherosclerosis, the chronic inflammatory disease responsible for most heart attacks and strokes. By synthesizing the latest evidence, the researchers show how different populations of these immune cells can either fuel inflammation or help regulate it, revealing new opportunities to better understand, diagnose and eventually treat cardiovascular disease. The review also identifies important gaps in current knowledge and outlines promising directions for future research. As scientists continue to better understand how these immune cells behave within arterial plaques, their discoveries could lead to more precise diagnostic tools and a new generation of immune-targeted therapies for cardiovascular disease. Together, the researchers' work offers journalists valuable insight into one of the fastest-evolving areas of cardiovascular research, where immunology and heart health are converging to reshape how cardiovascular disease is understood and treated. "This study highlights the major role of CD8+ T cells in atherosclerosis and their potential impact on cardiovascular diseases."  Hossam Abdelsamed, PhD To learn more about this amazing research and connect with Ishita Tandon, Hossam Abdelsamed or Alaa M. Khalifa, contact AU's External Communications Team mediarelations@augusta.edu to arrange an interview today.

View all posts
Powered by